tend to disagree,did you read the quarterly as its on track for testing glaucoma,with r+d refund 5 mil in the bank more than the market cap.
NSB is working with a highly experienced and qualified regulatory consultancy that holds
offices in UK, EU, US and Australia, to ensure that NSB can gain as much insight from the FDA
and confirm that the development plan in place for EmtinB within Ophthalmology is within
the regulator's expectations to allow the initiation of a clinical trial.
It is expected that this submission will occur in Q1 2024.
Currently a buy for me again
- Forums
- ASX - By Stock
- NSB
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-3
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
0.003(8.33%) |
Mkt cap ! $5.639M |
Open | High | Low | Value | Volume |
4.0¢ | 4.0¢ | 3.9¢ | $13.29K | 333.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 165471 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 263477 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 165471 | 0.037 |
2 | 365000 | 0.036 |
3 | 210000 | 0.035 |
1 | 100000 | 0.034 |
5 | 290133 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 263477 | 1 |
0.041 | 83333 | 1 |
0.042 | 95000 | 2 |
0.043 | 240000 | 2 |
0.044 | 24875 | 1 |
Last trade - 14.14pm 09/10/2024 (20 minute delay) ? |
Featured News
NSB (ASX) Chart |
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online